eHealth, Inc. — Form 8-K
Filed August 4, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 48/100
What the filing says
eHealth reported Q2 2026 total revenue of $33.6M (down 45% YoY from $60.8M), with GAAP net loss of $23.6M (vs. $17.4M loss prior year). The company deliberately reduced Medicare enrollment volume outside peak seasons to focus marketing spend and boost member engagement via its new Lifetime Advisory model, which showed early traction (ancillary cross-sell rates doubled YoY). Operating cash flow improved to negative $5.0M from negative $41.2M YoY. Full-year 2026 guidance reiterated: revenue $405M–$445M; GAAP net income $8M–$25M; Adjusted EBITDA $55M–$75M; operating cash flow ($10M) to $12M.
Why this rating
Strategic pivot showing near-term pain (45% revenue decline, widening losses) for structural model improvement; cash flow materially better; commissions receivable $1.0B (87% of market cap) appears healthy with 10% YoY growth, suggesting real underlying value. Timing of results reflects deliberate Q2/Q3 deferral; full-year guidance reiterated. Moderate for size: event is material relative to ~$126M market cap, but execution risk on turnaround remains.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.